Abstract
RNA Interference (RNAi) has emerged as a breakthrough in the life sciences
industry. It presents extensive potential in multiple areas, such as drug
discovery, drug development, and therapeutic applications for various
indications along with aiding in the basic research. It has been found that,
various components, such as siRNA & miRNA possess immense opportunities and
provides a wide range in different drug classes. Besides, these molecules find
wide applications in various sectors, such as functional genomics, disease
diagnostics, and agriculture, among others. Our study indicates that, the
usage of siRNA and miRNA in industries and academic institutions will witness
a substantial growth with the passage of time.
According to our new research report “Global RNAi Market
Analysis”, the global RNAi market is anticipated to grow stupendously at
a CAGR of around 28% during 2010 - 2015. Incessant growth of the industry will
be mainly driven by the rising utilization of this expertise as a research
gizmo in functional genomics, which is used in drug discovery, target
validation, and drug development along with agricultural & plant biotechnology
sectors. It is believed that, the RNAi market will also be driven by the
advancement of RNAi-based therapeutics for multiple indications in future.
Our report identifies that, at the segment level, Nanoparticle RNAi delivery
holds the maximum share in the global market. However, share of RNAi delivery
through Nucleic Acid & Aptamer will experience substantial growth in the
coming years.
Companies are flourishing by synthesizing dsRNAs and pools for RNAs, providing
vectors, transfection reagents, transfection apparatus, and enzymes for
creating dsRNAs that do not require synthetic RNAs. Further, RNAi gene
silencing has attracted a large amount of investment; perhaps more than since
the advent of PCR or gene sequencing.
The report provides extensive information and rational analysis of the global
RNAi market. It has thoroughly examined market applications, industrial
developments, and competitive landscapes to enable clients understand the
market structure and its progress in coming years. The report also provides
an insight into the different products available in the market at the segment
level.
Besides, the research contains exhaustive information regarding recent
developments in the geographical markets that will help clients in formulating
market strategies and assess opportunity areas in the Global RNAi market.
Table of Contents
1. Analyst View
2. Research Methodology
3. RNAi - An Introduction
4. Recent Industry Trends
- 4.1. Demand for High-Throughput Target Discovery
- 4.2. Demand for Target Validation
- 4.3. Pharmas Eyeing Product Specific Deals
- 4.4. Systemic Delivery for RNAi
5. Industry Overview
- 5.1. Market Size & Growth
- 5.2. Industry Applications
- 5.2.1. Conventional Drug Discovery
- 5.2.2. Drug Development
- 5.2.3. Basic Research
- 5.2.4. Therapeutics
6. RNAi Market by Product Segments
- 6.1. Existing Products
- 6.1.1. RNAi Reagents
- 6.1.2. RNAi Vectors
- 6.1.3. RNAi Transfection
- 6.1.4. RNAi Assays
- 6.1.5. RNAi Analysis
- 6.1.6. RNAi Libraries
- 6.1.7. RNAi Services
- 6.1.8. RNAi Controls
- 6.2. Pipeline Products
7. Geographical Markets
- 7.1. US
- 7.2. Europe
- 7.3. Asia Pacific
8. Competitive Landscape
- 8.1. Applied Biosystems
- 8.2. Bioneer
- 8.3. Qiagen
- 8.4. Genetix Ltd
- 8.5. Life Technologies
- 8.6. Sigma Aldrich Corporation
- 8.7. Tekmira Pharmaceuticals
- 8.8. Mirna Therapeutics
- 8.9. RXi Pharmaceuticals
- 8.10. Alnylam Pharmaceuticals
List of Figures:
- Figure 3-1: Process of Viral Replication
- Figure 3-2: RNAi Action Mechanism
- Figure 3-3: Processing of dsRNA & shRNA
- Figure 5-1: Global - RNAi Drug Delivery Market (Billion US$), 2010 & 2015
- Figure 5-2: Global - RNAi Drug Delivery Market by Technology (%), 2010
- Figure 5-3: Global - Forecast for RNAi Drug Delivery Market by Technology
(%), 2015
- Figure 5-4: RNAi Development Timeline v/s Monoclonal Antibodies
List of Tables:
- Table 5-1: Advantages of RNAi Therapies over Conventional Drugs
- Table 6-1: RNAi Reagent Products by Supplier
- Table 6-2: RNAi Vector Products by Supplier
- Table 6-3: RNAi Transfection Products by Supplier
- Table 6-4: RNAi Assays by Supplier
- Table 6-5: RNAi Analysis Products by Supplier
- Table 6-6: RNAi Library Products by Supplier
- Table 6-7: RNAi Services by Supplier
- Table 6-8: RNAi Control Products by Supplier
- Table 6-9: US - RNAi Clinical Status of Leading Companies
